MRK
Merck & Company, Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#224 today
$144.30
+0.34% today · -3.01% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- MRK +0.34% on the last session vs SPY +0.74%: −0.4 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 71 big drops in the past 5 years, MRK typically gained 1.5% over the next month (median) and was higher 58% of the time; half the outcomes fell between -2.3% and +4.8%. An ordinary month: +1.3%. Among S&P 500 stocks after big drops, that ranks #263 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $356.0B
- Held by institutions
- 83.0%
- Short interest
- 1.4%
- 52-week range
- 82.01–156.92
- Analyst mean target
- —
- Next earnings
- Oct 29 BMO
- Forward P/E
- 15.2
Recent events
Earnings ▲
2Q2026 results: EPS −$0.13 vs −$0.26 expected beat +$0.13 (+49.4%); revenue $16.6B; next session +0.2% (-1.6 vs SPY)Earnings ▲
1Q2026 results: EPS −$1.28 vs −$1.47 expected beat +$0.19 (+13.2%); revenue $16.3B; next session -1.6% (-2.6 vs SPY)Earnings ▲
4Q2025 results: EPS $2.04 vs $2.01 expected beat +$0.03 (+1.5%); revenue $16.4B; next session +2.2% (+3.0 vs SPY)